Tumour Site
 
Total (n=218)
Characteristics
Testicular (n=40)
Ovarian (n=105)
      EG (n=72)
 
n
%
Sex
 
 
 
 
 
 
Male
40
0
20
 
60
27.6
Female
0
106
52
 
158
72.4
Age 
 
 
 
 
 
 
0 to 4
35
13
59
 
107
49.1
5 to 9
2
29
6
 
37
17.0
10 to 14
2
58
6
 
66
30.2
³15
1
6
1
 
8
3.7
Tumour site
 
 
 
 
 
 
Ovarian
0
106
0
 
106
48.6
Testicular
40
0
0
 
40
18.3
Retroperitoneal
0
0
30
 
30
13.7
Abdomen
0
0
13
 
13
6.0
Mediastinal
0
0
13
 
13
6.0
Sacrococcygeal
0
0
11
 
11
6.0
Head & Neck
0
0
5
 
5
2.3
Histology
 
 
 
 
 
 
Yolk sac tumour
31
37
51
 
119
54.6
Mixed germ cell tumour
3
14
15
 
32
14.7
Embryonal carcinoma
3
5
0
 
8
3.7
Choriocarcinoma 
0
1
1
 
2
0.9
Dysgerminoma 
0
49
4
 
53
24.3
Seminoma 
3
0
1
 
4
1.8
Stage
 
 
 
 
 
 
I
19
27
13
 
59
27.0
II
5
22
10
 
37
17.0
III
9
39
27
 
75
34.4
IV
7
18
21
 
46
21.1
Missing
0
0
1
 
1
0.5
Stunted
 
 
 
 
 
 
None
35
88
64
 
187
85.8
Moderate
1
12
3
 
16
7.3
Severe
2
4
5
 
11
5.0
Missing
2
2
0
 
4
1.8
Wasted
 
 
 
 
 
 
None
38
91
61
 
190
87.1
Moderate
0
6
6
 
12
5.5
Severe
0
7
5
 
12
5.5
Missing
2
2
0
 
4
1.8
UWFA
 
 
 
 
 
 
None
35
82
58
 
175
80.3
Moderate
4
17
10
 
31
14.2
Severe
0
5
4
 
9
4.1
Missing
1
2
0
 
3
1.4
AFP [ng/mL]
 
 
 
 
 
 
0 to 9999
19
22
19
 
60
27.5
³ 10000
12
36
42
 
90
41.3
Missing
9
48
11
 
68
31.2
Treatment Regimen
 
 
 
 
 
 
No chemotherapy
15
7
4
 
26
11.9
JEb
13
38
37
 
88
40.4
PEb
1
2
4
 
7
3.2
BEP
10
53
22
 
85
39.0
Other
1
1
5
 
12
5.5